☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Kazia Therapeutics
Kazia Therapeutics and Sovargen Collaborate to Develop Paxalisib for Treating Intractable Seizures in Rare CNS Diseases
March 22, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.